Use of the Anti-interleukin-5-Receptor Monoclonal Antibody, Benralizumab, for the Treatment of Allergic Bronchopulmonary Aspergillosis
Year: 2024
Type: conference-abstract
Authors: S. Razi, R.J. Mcguire, J.G. Krings
Institution: Washington University in St. Louis
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396516281
